Retatrutide is a new medication in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By stimulating these receptors, https://brendafqmn323088.worldblogged.com/42385456/tirzepatide-a-promising-new-treatment-for-obesity